Indian Journal of Rheumatology

Scope & Guideline

Connecting researchers and practitioners in the realm of rheumatology.

Introduction

Welcome to the Indian Journal of Rheumatology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Indian Journal of Rheumatology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0973-3698
PublisherSAGE PUBLICATIONS INC
Support Open AccessYes
CountryIndia
TypeJournal
Convergefrom 2007 to 2023
AbbreviationINDIAN J RHEUMATOL / Indian J. Rheumatol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2455 TELLER RD, THOUSAND OAKS, CA 91320

Aims and Scopes

The Indian Journal of Rheumatology aims to advance the understanding of rheumatic diseases through comprehensive research that spans clinical, epidemiological, and therapeutic aspects. The journal emphasizes studies that are relevant to the Indian population and seeks to address the unique challenges faced in the management of rheumatic conditions in this context.
  1. Clinical Research in Rheumatology:
    The journal publishes clinical studies that investigate various rheumatic diseases, focusing on their diagnosis, treatment, and management, particularly in the Indian context.
  2. Epidemiology of Rheumatic Diseases:
    Research exploring the prevalence and epidemiological trends of rheumatic diseases in India, addressing how these conditions affect different demographics and regions.
  3. Innovative Therapeutic Approaches:
    Papers discussing new and existing therapeutic modalities, including biologics and targeted therapies, as well as traditional treatment approaches tailored for Indian patients.
  4. Diagnostic Advances:
    Studies that focus on improving diagnostic accuracy and methodologies in rheumatology, including the use of imaging techniques and biomarkers.
  5. Patient-Centered Outcomes and Quality of Life:
    Research assessing patient-reported outcomes, quality of life, and psychosocial aspects of living with rheumatic diseases, with an emphasis on Indian populations.
  6. Health Economics and Policy:
    Investigations into the economic burden of rheumatic diseases and the impact of health policies on patient care and access to treatment.
  7. Education and Training in Rheumatology:
    Contributions focusing on improving education and training for healthcare professionals in the field of rheumatology, including the introduction of new technologies and methodologies.
The Indian Journal of Rheumatology has identified several emerging themes that reflect the evolving landscape of rheumatology research. These trends highlight the journal's commitment to addressing contemporary issues and utilizing innovative methodologies.
  1. Digital Health and Telemedicine:
    There is a growing emphasis on research related to telemedicine and digital health solutions, especially following the COVID-19 pandemic, indicating a shift in how rheumatology care is delivered.
  2. Artificial Intelligence and Machine Learning in Rheumatology:
    The integration of AI and machine learning technologies for enhancing diagnostics and treatment plans is gaining traction, showcasing a forward-thinking approach in rheumatology.
  3. Long COVID and Its Impact on Rheumatic Diseases:
    Increasing publications addressing the intersection of COVID-19 and rheumatic diseases, particularly in relation to long-term outcomes and management strategies.
  4. Patient-Centered Care and Quality of Life Studies:
    A notable rise in research focusing on patient experiences, adherence to treatment, and quality of life metrics, emphasizing the importance of holistic approaches in rheumatology.
  5. Health Economics and Access to Care:
    Emerging themes on the economic implications of rheumatic diseases, including cost-effectiveness and healthcare access issues, are becoming more prominent within the journal.
  6. Biomarkers and Precision Medicine:
    Studies investigating novel biomarkers for early diagnosis and personalized treatment plans are increasingly featured, reflecting advancements in precision medicine.

Declining or Waning

While the Indian Journal of Rheumatology has a robust focus on various aspects of rheumatology, certain themes have seen a decline in prominence over recent years. These waning areas may reflect shifting priorities in research or changes in clinical practice.
  1. Traditional Treatment Modalities:
    Research focusing on conventional treatments without the integration of new therapeutic advancements appears to be decreasing, as the field increasingly shifts towards innovative and targeted therapies.
  2. Basic Science Research:
    There has been a noticeable decline in studies centered on fundamental biological mechanisms of rheumatic diseases, as the journal emphasizes more clinical and applied research.
  3. Rare Disease Reports:
    Papers detailing rare rheumatic conditions or atypical presentations have become less frequent, possibly due to the broader focus on more prevalent diseases that impact larger populations.
  4. Historical Perspectives in Rheumatology:
    Articles reflecting on the historical evolution of rheumatology practices and treatments are less common, indicating a shift towards contemporary issues and future directions.
  5. Case Reports:
    The volume of detailed case reports has decreased, as the journal moves towards publishing more comprehensive studies with larger sample sizes and broader implications.

Similar Journals

RMD Open

Leading the way in open-access rheumatology research.
Publisher: BMJ PUBLISHING GROUPISSN: 2056-5933Frequency: 2 issues/year

RMD Open, published by the BMJ Publishing Group, is a leading open-access journal that has made significant contributions to the fields of Immunology, Immunology and Allergy, and Rheumatology since its inception in 2015. With an impressive Q1 ranking in these categories for 2023, the journal has established itself as an essential platform for the dissemination of high-quality research, case studies, and reviews that advance understanding and treatment strategies in these critical areas of health. As an open-access publication, RMD Open ensures that its content is freely accessible to a global audience, promoting collaboration and knowledge sharing among researchers, clinicians, and students. Based in the United Kingdom at the British Medical Association House, RMD Open is not only dedicated to improving patient care but also to fostering innovative research and discussions in the rapidly evolving landscape of rheumatic diseases.

RHEUMATOLOGY INTERNATIONAL

Elevating the standards of rheumatological science.
Publisher: SPRINGER HEIDELBERGISSN: 0172-8172Frequency: 12 issues/year

Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Championing rigorous research in rheumatological sciences.
Publisher: CLINICAL & EXPER RHEUMATOLOGYISSN: 0392-856XFrequency: 6 issues/year

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is a prestigious journal published by CLINICAL & EXPER RHEUMATOLOGY, dedicated to advancing the field of rheumatology and immunology. With a rich history dating back to 1983, the journal serves as a critical platform for researchers, clinicians, and professionals seeking to disseminate and discuss innovative findings in these rapidly evolving areas. Featuring an impressive Q2 ranking in both Immunology and Allergy, as well as Rheumatology, this journal is recognized for its high-quality contributions, placing it among the top tier of academic publications. Operating without an open access model, CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is headquartered in Pisa, Italy, and publishes articles that undergo rigorous peer review to ensure excellence in research. This journal is an invaluable resource for those dedicated to improving patient outcomes through evidence-based practice in rheumatology, immunology, and related fields.

CURRENT OPINION IN RHEUMATOLOGY

Navigating the Frontiers of Rheumatic Disease Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1040-8711Frequency: 6 issues/year

Current Opinion in Rheumatology, published by Lippincott Williams & Wilkins, stands as a vital resource in the field of rheumatology. Since its inception in 1989, this prestigious journal has been at the forefront of disseminating cutting-edge research, with a notable Q1 ranking in the 2023 Rheumatology category and an impressive Scopus rank of 7 out of 73, placing it in the 91st percentile. The journal's commitment to presenting insightful reviews and critical analyses of recent advancements and treatment strategies makes it an essential read for professionals, researchers, and students dedicated to the study of rheumatic diseases. Although not an open-access journal, Current Opinion in Rheumatology continues to foster an informed dialogue within the academic community through its high-impact content, ensuring that the latest developments and practices are accessible to those at the vanguard of rheumatology research.

Archives of Rheumatology

Elevating the standards of rheumatology through shared knowledge.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Pioneering Innovations in Rheumatic Disease Management
Publisher: TAYLOR & FRANCIS LTDISSN: 0300-9742Frequency: 6 issues/year

The Scandinavian Journal of Rheumatology, published by Taylor & Francis Ltd, is a prestigious peer-reviewed journal dedicated to advancing research in the fields of rheumatology, immunology, and related disciplines. With an ISSN of 0300-9742 and an E-ISSN of 1502-7732, this journal has established itself as a vital platform for disseminating significant findings and innovative approaches in the management of rheumatic diseases since its inception in 1959. As a recognized scholarly outlet, it currently resides within the Q2 category for Medicine (miscellaneous) and ranks #39 out of 73 in Rheumatology according to the 2023 Scopus assessments. This reflects the journal's commitment to high-quality research and its relevance in the scientific community. Although it does not provide Open Access options, the journal's rigorous selection process ensures that only the most impactful research reaches its audience, making it a crucial resource for researchers, clinicians, and students engaged in the exploration of rheumatological and immunological challenges. The journal's broad scope encompasses ongoing studies, clinical trials, and reviews that aim to enhance understanding and treatment of rheumatic conditions, promoting collaboration and knowledge-sharing among professionals in the field.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Enhancing Insights into Rheumatic Disorders
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1076-1608Frequency: 8 issues/year

JCR-Journal of Clinical Rheumatology, published by Lippincott Williams & Wilkins, is a premier outlet dedicated to the field of rheumatology, recognized for its contributions and relevance among medical journals. Boasting an impact factor reflective of its vital role in disseminating innovative research, it currently holds a Q2 category ranking in Medicine (miscellaneous) and a Q3 ranking in Rheumatology as of 2023. With its convergence years spanning from 1995 to 2024, the journal aims to foster the advancement of knowledge in clinical practices, therapeutic advances, and patient management strategies concerning rheumatic diseases. Researchers, professionals, and students can access a wealth of benchmark studies and peer-reviewed articles, enhancing their understanding and collaboration within this dynamic field. By bridging clinical insights with rigorous research, the JCR-Journal of Clinical Rheumatology remains an important resource for advancing the understanding of rheumatologic disorders and improving patient care.

ANNALS OF THE RHEUMATIC DISEASES

Advancing the Frontiers of Rheumatology Research
Publisher: BMJ PUBLISHING GROUPISSN: 0003-4967Frequency: 12 issues/year

ANNALS OF THE RHEUMATIC DISEASES, published by BMJ Publishing Group, stands as a leading academic journal in the realm of rheumatology and related fields, including biochemistry, immunology, and genetics. With an esteemed impact factor and a consistent ranking in the upper echelons of its category (Q1) as per the latest evaluations, this journal represents the forefront of research and innovation, fostering scientific advancement from 1945 to the present. As the top journal in the Medicine - Rheumatology category and achieving remarkable percentiles in various interdisciplinary categories, it serves as a critical platform for researchers, clinicians, and students dedicated to understanding and addressing rheumatic diseases. Although it does not currently offer open access, its rigorous peer-review process ensures the dissemination of high-quality research findings that are paramount in enhancing clinical practices and advancing scientific discourse. Readers can expect to be challenged and inspired by the breadth of studies and reviews that address the complexities of rheumatology and its intersecting scientific domains.

European Journal of Rheumatology

Bridging Science and Practice in Rheumatology
Publisher: AVESISSN: 2147-9720Frequency: 4 issues/year

European Journal of Rheumatology is a premier, peer-reviewed journal that has been paving the way for innovative research and in-depth analysis in the field of rheumatology since its launch. Published by AVES, this Open Access journal has been accessible to researchers, professionals, and students worldwide since 2014, promoting the sharing of valuable knowledge on rheumatic diseases and their treatment. With an ISSN of 2147-9720 and an E-ISSN of 2148-4279, it provides a prominent platform for groundbreaking studies and clinical evaluations that bridge scientific discovery with practical application. The journal’s mission is to enhance the understanding of rheumatological conditions and facilitate advancements in therapeutic strategies, making it an essential resource for anyone devoted to the improvement of patient care in this dynamic field. The European Journal of Rheumatology is committed to upholding the highest standards of scholarly publishing and aims to foster collaboration among researchers and practitioners across Europe and beyond.

Advances in Rheumatology

Championing excellence in rheumatology research and practice.
Publisher: BMCISSN: 2523-3106Frequency: 1 issue/year

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.